A screening procedure examines cells collected from the cervix to detect potential abnormalities, including precancerous and cancerous conditions. It is primarily designed to identify cellular changes indicative of cervical cancer or its precursors. However, this examination is not intended as a primary diagnostic tool for sexually transmitted diseases. Specific testing methodologies are required to accurately identify the presence of STDs.
The procedure plays a vital role in preventative healthcare for individuals with a cervix. Early detection of cellular abnormalities through this screening can significantly improve treatment outcomes for cervical cancer. While not designed for STD detection, certain infections may sometimes be suggested by cellular changes observed during the screening process. This has prompted ongoing research into the potential for expanded applications in the realm of sexual health.